Adma Biologics Inc Ingresos Q/Q
¿Qué es el Ingresos Q/Q de Adma Biologics Inc?
El Ingresos Q/Q de Adma Biologics Inc es 78.29%
¿Cuál es la definición de Ingresos Q/Q?
El crecimiento de los ingresos trimestrales, año tras año, es el aumento de los ingresos de una empresa en comparación con el compiortamiento en el trimestre correspondiente de un año anterior expresado como un porcentaje.
Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.
Ingresos Q/Q de compañías en Sector Health Care en NASDAQ en comparadas con Adma Biologics Inc
¿Qué hace Adma Biologics Inc?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Empresas con ingresos q/q similar a Adma Biologics Inc
- Great Portland Estates Plc tiene Ingresos Q/Q de 78.02%
- Ansal Housing & Construction tiene Ingresos Q/Q de 78.07%
- Dealnet Capital tiene Ingresos Q/Q de 78.07%
- Orient Bell tiene Ingresos Q/Q de 78.16%
- Alfen N.V tiene Ingresos Q/Q de 78.19%
- Catella AB (publ) tiene Ingresos Q/Q de 78.26%
- Adma Biologics Inc tiene Ingresos Q/Q de 78.29%
- Dhunseri Investments tiene Ingresos Q/Q de 78.39%
- Sterling Consolidated tiene Ingresos Q/Q de 78.49%
- Sreeleathers tiene Ingresos Q/Q de 78.52%
- Tantech Ltd tiene Ingresos Q/Q de 78.56%
- Vikas EcoTech tiene Ingresos Q/Q de 78.56%
- Masimo tiene Ingresos Q/Q de 78.68%